You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

Citations 31-40 of 113 total displayed.

Past content (since Sep 1999):

From JAMA
High-Dose B Vitamin Supplementation as a Disease-Modifying Therapy in Alzheimer Disease
Anand Viswanathan
Arch Neurol 2009; 66: 520-522. [Extract] [Full text] [PDF]  

Correspondence
Can Treatment With Nonsteroidal Anti-inflammatory Drugs Protect From Dementia?
Noa Bregman; Arnon Karni; Amos D. Korczyn
Arch Neurol 2009; 66: 539-a-540-a. [Extract] [Full text] [PDF]  

Correspondence
Tissue Plasminogen Activator Does Not Benefit Most Eligible Patients With Stroke
Maarten G. Lansberg; Neil E. Schwartz
Arch Neurol 2009; 66: 540-a-541-a. [Extract] [Full text] [PDF]  

Correspondence
Can Treatment With Nonsteroidal Anti-inflammatory Drugs Protect From Dementia?—Reply
Barbara K. Martin; Jason Brandt; John C. S. Breitner; Suzanne Craft; Denis Evans; Robert Green; Michael Mullan; Steven Piantadosi; Christine Szekely
Arch Neurol 2009; 66: 540. [Extract] [Full text] [PDF]  

Correspondence
Tissue Plasminogen Activator Does Not Benefit Most Eligible Patients With Stroke—Reply
Bryan A. Liang; Robert Lew; Justin A. Zivin
Arch Neurol 2009; 66: 541. [Extract] [Full text] [PDF]  

Clinical Trials
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009.32. [Abstract] [Full text] []  

Clinical Implications of Basic Neuroscience Research
Implications of Amylin Receptor Agonism: Integrated Neurohormonal Mechanisms and Therapeutic Applications
Jonathan D. Roth; Holly Maier; Steve Chen; Barbara L. Roland
Arch Neurol 2009; 66: 306-310. [Extract] [Full text] [PDF]  

Observations
Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy
Deanna Cettomai; Justin C. McArthur
Arch Neurol 2009; 66: 255-258. [Abstract] [Full text] [PDF]  

Observations
Long-term B-Lymphocyte Depletion With Rituximab in Patients With Relapsing-Remitting Multiple Sclerosis
Olaf Stüve; Verena I. Leussink; Ruth Fröhlich; Bernhard Hemmer; Hans-Peter Hartung; Til Menge; Bernd C. Kieseier
Arch Neurol 2009; 66: 259-261. [Abstract] [Full text] [PDF]  

Editorials
Defining Multiple Sclerosis Treatment Response With Magnetic Resonance Imaging: How Much Activity Is Too Much?
Paul S. Giacomini; Douglas L. Arnold; Amit Bar-Or; Jack P. Antel
Arch Neurol 2009; 66: 19-20. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.